X-43949817-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000266.4(NDP):c.384C>A(p.Cys128*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 23)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
NDP
NM_000266.4 stop_gained
NM_000266.4 stop_gained
Scores
1
1
3
Clinical Significance
Conservation
PhyloP100: -0.256
Genes affected
NDP (HGNC:7678): (norrin cystine knot growth factor NDP) This gene encodes a secreted protein with a cystein-knot motif that activates the Wnt/beta-catenin pathway. The protein forms disulfide-linked oligomers in the extracellular matrix. Mutations in this gene result in Norrie disease and X-linked exudative vitreoretinopathy. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0448 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-43949817-G-T is Pathogenic according to our data. Variant chrX-43949817-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 10686.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-43949817-G-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDP | ENST00000642620.1 | c.384C>A | p.Cys128* | stop_gained | 3/3 | NM_000266.4 | ENSP00000495972.1 | |||
NDP | ENST00000647044.1 | c.384C>A | p.Cys128* | stop_gained | 4/4 | ENSP00000495811.1 | ||||
NDP-AS1 | ENST00000435093.1 | n.86G>T | non_coding_transcript_exon_variant | 1/5 | 3 | |||||
NDP | ENST00000470584.1 | n.428C>A | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1064123Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 346527
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1064123
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
346527
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2021 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the NDP protein in which other variant(s) (p.Cys131*) have been determined to be pathogenic (PMID: 25711638; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 10686). This variant is also known as C792A (Cys128stp). This premature translational stop signal has been observed in individuals with Norrie disease (PMID: 7627181, 8240113). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Cys128*) in the NDP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 6 amino acid(s) of the NDP protein. - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 10, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2015 | The C128X nonsense variant in the NDP gene has been reported previously in association with Norriedisease (Wong et al., 1993; Schuback et al., 1995). This variant is predicted to cause loss of normal protein function through protein truncation. Therefore, we interpret this variant as pathogenic. - |
Atrophia bulborum hereditaria Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1993 | - - |
Pathogenic, criteria provided, single submitter | research | Molecular Medicine, University of Pavia | Jul 28, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
Vest4
0.89
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at